Rhodes Jason P

DirectorGeneration Bio Co. (GBIO) · full profile →Form 4 · filed Feb 9, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
9
3 non-derivative · 6 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 9, 2026Tender(U)600
Feb 9, 2026Tender(U)711K0
Feb 9, 2026Tender(U)117K0

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Feb 9, 2026Disposed to issuer(D)2K0
Feb 9, 2026Disposed to issuer(D)2K0
Feb 9, 2026Disposed to issuer(D)3K0
Feb 9, 2026Disposed to issuer(D)5K0
Feb 9, 2026Disposed to issuer(D)6K0
Feb 9, 2026Disposed to issuer(D)3K0

Transaction Codes

U
See SEC Form 4 code table
D
Disposition to the issuer

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-26-012195) within minutes of acceptance. Every field above traces to the original document. Verify it directly: